Thursday, October 29, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 16.9
The market is in a sharp rotation: mega-cap tech and high-multiple growth names (META, GOOGL, NFLX, AVGO, MRVL, NVDA) are selling off hard on disappointing guidance, while energy, healthcare/medtech, industrials, insurance, and select financials are grinding to new 52-week highs on steady multi-week momentum. Breadth outside tech looks constructive, so selective long exposure in the leaders of this rotation looks more attractive than chasing the beaten-down growth names.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | DGX | SKIP | — | $251.88 → $265.22 stop $233.24 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #2 | ACGL | SKIP | — | $103.99 → $109.31 stop $97.75 |
Position cap reached — 88 of 20 slots in use. |
| #3 | EMR | SKIP | — | $169.94 → $178.44 stop $159.91 |
Position cap reached — 88 of 20 slots in use. |
| #4 | BLK | SKIP | — | $1,169.62 → $1,232.08 stop $1,097.10 |
Position cap reached — 88 of 20 slots in use. |
| #5 | TMO | SKIP | — | $705.75 → $742.20 stop $652.82 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
Already open: ALW.L (to Nov 1), MSFT (to Nov 4), AMZN (to Nov 8), PYPL (to Nov 8), HUM (to Nov 11), TJX (to Nov 11), BNZL.L (to Nov 12), LIN (to Nov 13), GILD (to Nov 14), UNH (to Nov 14), WMT (to Nov 14), CTEC.L (to Nov 14) … and 76 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Quest Diagnostics runs medical testing labs across the country. Its stock has quietly outperformed the market over the past month with healthy, sustainable momentum, and because it already reported earnings last week, there's no earnings surprise risk left in the next 30 days. The main risk is a broader healthcare-sector pullback or a reimbursement/regulatory headline.
Why the AI likes it
What could go wrong
Calibrated probability: 56% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Arch Capital is a global insurance and reinsurance company. After beating earnings expectations a few days ago, its shares are trending higher with healthy momentum and no overbought warning signs, fitting the market's current rotation into insurance and financial names. The main risk is an unexpected large claims event, like a natural disaster, that wouldn't show up in the price chart ahead of time.
Why the AI likes it
What could go wrong
Calibrated probability: 56% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Emerson Electric makes industrial automation and process-control equipment used in factories and energy plants. Its stock is climbing steadily with healthy (not overheated) momentum, a bullish technical crossover, and a tightening price range that often precedes a breakout — all while industrials lead the current market rotation. The main risk is that a broad market pullback or cautious comments at its upcoming earnings call could stall the rally.
Why the AI likes it
What could go wrong
Calibrated probability: 60% (raw model estimate: 72%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
BlackRock is the world's largest asset manager, running investment funds including the popular iShares ETFs. Its shares have climbed steadily and are beating the market, supported by healthy technical readings, fitting the market's current preference for financial names. The main risk is that a market-wide downturn would reduce the value of the assets it manages, hurting its fees and the stock.
Why the AI likes it
What could go wrong
Calibrated probability: 56% (raw model estimate: 69%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Thermo Fisher Scientific supplies lab instruments and equipment used across the pharmaceutical and research industries. Its uptrend is more modest than some peers but is backed by healthy, not-overbought momentum, and its most recent earnings report is already behind it, removing near-term earnings risk from this pick's window. The main risk is that demand for its equipment is tied to biotech/pharma research budgets, which can soften if funding tightens.
Why the AI likes it
What could go wrong
Calibrated probability: 56% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by November 28, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 503 S&P 500 constituents and short-listed 27 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.